However, more recent studies found PXN was overexpressed and acted as an pro-oncogene in a variety of tumors, including non-small cell lung cancer, colorectal cancer, prostate cancer and cervical carcinoma [15-20]. The gene discussed is PXN; the disease is non-small cell lung carcinoma.